All Global Research articles can be read in 51 languages by activating the “Translate Website” drop down menu on the top banner of our home page (Desktop version).
To receive Global Research’s Daily Newsletter (selected articles), click here.
Follow us on Instagram and Twitter and subscribe to our Telegram Channel. Feel free to repost and share widely Global Research articles.
***
Guest: Dr. Hedley Rees – Managing Director of Pharmaflow, author and advocate for modernisation of the pharmaceutical industry. He held senior positions at Bayer UK, British Biotech, Vernalis and others. He is also author of Taming The Big Pharma Monster: by Speaking Truth to Power (2019).
In this session, the panel discusses that there is evidence that the drugs were rushed to market, taking significant shortcuts to make money rather than offering the safest and most effective product possible. Further in the discussion are:
How MHRA/EMA did not follow its own rules and guidelines described in its Orange Guide. They did not meet
their very own terms for conditional approval of the injections.
How -70°C (ultra-frozen) injections were a gross contravention of GMP, as they were not fully finished as unit doses on leaving the factory, and they had to circumvent pharmaceutical wholesalers (licensed to comply with GDP) because they were not equipped to handle those temperatures.
*
Note to readers: Please click the share buttons above or below. Follow us on Instagram and Twitter and subscribe to our Telegram Channel. Feel free to repost and share widely Global Research articles.
Disclaimer: The contents of this article are of sole responsibility of the author(s). The Centre for Research on Globalization will not be responsible for any inaccurate or incorrect statement in this article. The Centre of Research on Globalization grants permission to cross-post Global Research articles on community internet sites as long the source and copyright are acknowledged together with a hyperlink to the original Global Research article. For publication of Global Research articles in print or other forms including commercial internet sites, contact: [email protected]
www.globalresearch.ca contains copyrighted material the use of which has not always been specifically authorized by the copyright owner. We are making such material available to our readers under the provisions of "fair use" in an effort to advance a better understanding of political, economic and social issues. The material on this site is distributed without profit to those who have expressed a prior interest in receiving it for research and educational purposes. If you wish to use copyrighted material for purposes other than "fair use" you must request permission from the
copyright owner.
